Treatment of diastolic dysfunction in hypertension

Bella, 2002, Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the strong heart study, Circulation, 105, 1928, 10.1161/01.CIR.0000015076.37047.D9 Aurigemma, 2001, Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study, J Am Coll Cardiol, 37, 1042, 10.1016/S0735-1097(01)01110-X Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, J Am Med Assoc, 289, 194, 10.1001/jama.289.2.194 Kane, 2011, Progression of left ventricular diastolic dysfunction and risk of heart failure, J Am Med Assoc, 306, 856, 10.1001/jama.2011.1201 Schillaci, 2002, Prognostic significance of left ventricular diastolic dysfunction in essential hypertension, J Am Coll Cardiol, 39, 2005, 10.1016/S0735-1097(02)01896-X Owan, 2006, Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, 355, 251, 10.1056/NEJMoa052256 Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function, Circulation, 105, 1387, 10.1161/hc1102.105289 Solomon, 2010, Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction, Hypertension, 55, 241, 10.1161/HYPERTENSIONAHA.109.138529 Vasan, 1996, The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview, Arch Intern Med, 156, 1789, 10.1001/archinte.1996.00440150033003 Bella, 2005, Epidemiology of left ventricular hypertrophy and dilated cardiomyopathy, 477 Cutler, 2008, Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999–2004, Hypertension, 52, 818, 10.1161/HYPERTENSIONAHA.108.113357 Mancia, 2007, Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (esh) and of the European society of cardiology (ESC), Eur Heart J, 28, 1462 Chobanian, 2003, The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure, J Am Med Assoc, 289, 2560, 10.1001/jama.289.19.2560 Dickstein, 2008, Eur J Heart Fail, 10, 933, 10.1016/j.ejheart.2008.08.005 Hunt, 2005, J Am Coll Cardiol, 46, e1, 10.1016/j.jacc.2005.08.022 Wachtell, 2002, Change in diastolic left ventricular filling after one year of antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension (life) study, Circulation, 105, 1071, 10.1161/hc0902.104599 Ma, 2010, Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status, Br J Pharmacol, 160, 1273, 10.1111/j.1476-5381.2010.00750.x Terpstra, 2001, Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial, J Hypertens, 19, 303, 10.1097/00004872-200102000-00018 Yip, 2008, The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction, Heart, 94, 573, 10.1136/hrt.2007.117978 Muller-Brunotte, 2006, Am J Hypertens, 19, 927, 10.1016/j.amjhyper.2006.02.009 Solomon, 2007, Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial, Lancet, 369, 2079, 10.1016/S0140-6736(07)60980-5 Massie, 2008, Irbesartan in patients with heart failure and preserved ejection fraction, N Engl J Med, 359, 2456, 10.1056/NEJMoa0805450 Yusuf, 2003, Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial, Lancet, 362, 777, 10.1016/S0140-6736(03)14285-7 Wachtell, 2010, Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE study), Am J Cardiol, 106, 999, 10.1016/j.amjcard.2010.05.032 Bonow, 1992, Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management, Ann Intern Med, 117, 502, 10.7326/0003-4819-117-6-502 Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment, Circulation, 105, 1503, 10.1161/hc1202.105290 Nodari, 2003, Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol, Eur J Heart Fail, 5, 621, 10.1016/S1388-9842(03)00054-0 Flather, 2005, Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS), Eur Heart J, 26, 215, 10.1093/eurheartj/ehi115 Aronow, 1997, Am J Cardiol, 80, 207, 10.1016/S0002-9149(97)00320-2 Takeda, 2004, Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction, Am J Cardiol, 94, 448, 10.1016/j.amjcard.2004.05.004 Ventura, 1999, Treatment of the hypertensive patient with microvascular angina, Curr Opin Cardiol, 14, 370, 10.1097/00001573-199909000-00003 Tapp, 2010, Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (anglo-scandinavian cardiac outcomes trial) substudy, J Am Coll Cardiol, 55, 1875, 10.1016/j.jacc.2009.11.084 Setaro, 1990, Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance, Am J Cardiol, 66, 981, 10.1016/0002-9149(90)90937-V Ohtani, 2007, Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker, Am J Physiol Regul Integr Comp Physiol, 292, R946, 10.1152/ajpregu.00402.2006 Izawa, 2005, Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study, Circulation, 112, 2940, 10.1161/CIRCULATIONAHA.105.571653 Mottram, 2004, Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure, Circulation, 110, 558, 10.1161/01.CIR.0000138680.89536.A9 http://www.topcatstudy.com [accessed 29.09.11]. Galderisi, 2011, Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient, Am J Hypertens, 24, 507, 10.1038/ajh.2010.235 Wang, 2011, Role of ACE2 in diastolic and systolic heart failure, Heart Fail Rev